Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:380-388
Published online before print January 8, 2007, doi: 10.1161/01.HYP.0000255792.97033.f7
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
49/2/380    most recent
01.HYP.0000255792.97033.f7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heaton, D. A.
Right arrow Articles by Paterson, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heaton, D. A.
Right arrow Articles by Paterson, D. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies

(Hypertension. 2007;49:380.)
© 2007 American Heart Association, Inc.


Original Articles

Gene Transfer of Neuronal Nitric Oxide Synthase into Intracardiac Ganglia Reverses Vagal Impairment in Hypertensive Rats

Daniel A. Heaton; Dan Li; Susanna C. Almond; Tom A. Dawson; Lijun Wang; Keith M. Channon; David J. Paterson

From the Burdon Sanderson Cardiac Science Centre (D.A.H., D.L., S.C.A., T.A.D., L.W., D.J.P.), Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom; and the Department of Cardiovascular Medicine (K.M.C.), John Radcliffe Hospital, Oxford, United Kingdom.

Correspondence to David J. Paterson, Department of Physiology, Anatomy and Genetics, Sherrington Building Parks Rd, Oxford, United Kingdom OX1 3PT. E-mail david.paterson{at}physiol.ox.ac.uk

Hypertension is associated with reduced cardiac vagal activity and decreased atrial guanylate cyclase and cGMP levels. Neuronal production of NO facilitates cardiac parasympathetic transmission, although oxidative stress caused by hypertension may disrupt this pathway. We tested the hypothesis that peripheral vagal responsiveness is attenuated in the spontaneously hypertensive rat (SHR) because of impaired NO-cGMP signaling and that gene transfer of neuronal NO synthase (nNOS) into cholinergic intracardiac ganglia can restore neural function. Cardiac vagal heart rate responses in the isolated SHR atrial/right vagus preparation were significantly attenuated compared with age-matched normotensive Wistar–Kyoto rats. [3H] acetylcholine release was also significantly lower in the SHR. The NO donor, sodium nitroprusside, augmented vagal responses to nerve stimulation and [3H] acetylcholine release in the Wistar–Kyoto rat, whereas the soluble guanylate cyclase inhibitor 1H-(1,2,4)oxadiazolo(4,3-a)quinoxaline-1-one attenuated [3H] acetylcholine release in Wistar–Kyoto atria. No effects of sodium nitroprusside or 1H-(1,2,4)oxadiazolo(4,3-a)quinoxaline-1-one were seen in the SHR during nerve stimulation. In contrast, SHR atria were hyperresponsive to carbachol-induced bradycardia, with elevated production of atrial cGMP. After gene transfer of adenoviral nNOS into the right atrium, vagal responsiveness in vivo was significantly increased in the SHR compared with transfection with adenoviral enhanced green fluorescent protein. Atrial nNOS activity was increased after gene transfer of adenoviral nNOS, as was expression of {alpha}1-soluble guanylate cyclase in both groups compared with adenoviral enhanced green fluorescent protein. In conclusion, a significant component of cardiac vagal dysfunction in hypertension is attributed to an impairment of the postganglionic presynaptic NO-cGMP pathway and that overexpression of nNOS can reverse this neural phenotype.


Key Words: NO • gene transfer • autonomic nervous system • acetylcholine • heart rate • hypertension • guanylate cyclase




This article has been cited by other articles:


Home page
Int J EpidemiolHome page
M. D Tobin, M. Kahonen, P. Braund, T. Nieminen, C. Hajat, M. Tomaszewski, J. Viik, R. Lehtinen, G A. Ng, P. W Macfarlane, et al.
Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations
Int. J. Epidemiol., May 29, 2008; (2008) dyn091v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. K. Choate, S. M. Murphy, R. Feldman, and C. R. Anderson
Sympathetic control of heart rate in nNOS knockout mice
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H354 - H361.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. Li, L. Wang, C.-W. Lee, T. A. Dawson, and D. J. Paterson
Noradrenergic Cell Specific Gene Transfer With Neuronal Nitric Oxide Synthase Reduces Cardiac Sympathetic Neurotransmission in Hypertensive Rats
Hypertension, July 1, 2007; 50(1): 69 - 74.
[Abstract] [Full Text] [PDF]